Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A U Neumann

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Journal of Viral Hepatitis|September 29, 2009
Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatmentE Lukasiewicz, M Gorfine, L S Freedman, et al.
Science (New York, N.Y.)|October 2, 1998
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapyA U Neumann, N P Lam, H Dahari, et al.
Transplantation Proceedings|August 11, 2000
T cell repertoire alterations in allograft and xenograft rejection processesS Brouard, F Sebille, B Vanhove, et al.
Nature Medicine|February 14, 1998
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapyG Gorochov, A U Neumann, A Kereveur, et al.
The Journal of Infectious Diseases|July 7, 2000
Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virusA U Neumann, N P Lam, H Dahari, et al.
Nature Medicine|March 21, 1998
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutationL G Kostrikis, Y Huang, J P Moore, et al.
Science (New York, N.Y.)|April 26, 1996
Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infectionS M Wolinsky, B T Korber, A U Neumann, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
HIV Clinical Trials|August 9, 2013
Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infectionK J Cortez, M A Proschan, L Barrett, et al.
Journal of Viral Hepatitis|August 27, 2010
Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patientsE S A Araújo, H Dahari, A U Neumann, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Journal of Viral Hepatitis|September 29, 2009
Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatmentE Lukasiewicz, M Gorfine, L S Freedman, et al.
Science (New York, N.Y.)|October 2, 1998
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapyA U Neumann, N P Lam, H Dahari, et al.
Transplantation Proceedings|August 11, 2000
T cell repertoire alterations in allograft and xenograft rejection processesS Brouard, F Sebille, B Vanhove, et al.
Nature Medicine|February 14, 1998
Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapyG Gorochov, A U Neumann, A Kereveur, et al.
The Journal of Infectious Diseases|July 7, 2000
Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virusA U Neumann, N P Lam, H Dahari, et al.
Nature Medicine|March 21, 1998
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutationL G Kostrikis, Y Huang, J P Moore, et al.
Science (New York, N.Y.)|April 26, 1996
Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infectionS M Wolinsky, B T Korber, A U Neumann, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
HIV Clinical Trials|August 9, 2013
Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infectionK J Cortez, M A Proschan, L Barrett, et al.
Journal of Viral Hepatitis|August 27, 2010
Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patientsE S A Araújo, H Dahari, A U Neumann, et al.
Pageof 5